Medical Devices & Diagnostics · LP-207
Blood glucose test strips Diagnostic test
Device / diagnostic dossier. Catalogue identity is separated from unresolved product-specific fields and from external scientific references.
Development record
This dossier integrates an archived editorial source review dated 2026-09-11. Website reconciliation does not constitute a new medical or regulatory review. Controlled product approval, use instructions and supply status remain unestablished.
- Portfolio reference
- LP-207Medical Devices & Diagnostics
- Product type
- Blood glucose test stripsDiagnostic test
- Registration
- Not establishedProduct-specific evidence required
- Availability
- Not marketedNo offer of supply
01 · Layers 01–02 · Evidence boundary
What this public record establishes — and what remains held.
- Portfolio reference
- LP-207
- Product type
- Blood glucose test strips
- Presentation
- Diagnostic test
- Configuration / specification
- 25 strips; 50 strips
- Catalogue pack
- Vial/carton; supplied as a matched strip-and-meter system
- Public status
- Development presentation
Layer 01 · Controlled catalogue facts
- Product type: blood glucose test strips.
- Portfolio form/type: diagnostic test.
- Proposed count options: 25 strips and 50 strips.
- Catalogue pack wording: vial/carton; “compatible with selected glucometer”.
Layer 02 · Unresolved product-specific fields
- Manufacturer/model and exact compatible meter(s).
- Test chemistry, specimen type, measurement range, accuracy/performance and interference data.
- Coding/calibration and quality-control requirements.
- Storage/after-opening limits, intended users/settings, registration and supply status.
02 · Configurations
Keep device configuration separate from model and performance claims.
| Configuration | Catalogue value | Product type | Presentation detail | Packaging relationship | Evidence status |
|---|---|---|---|---|---|
| A | 25 strips | Diagnostic test strips | — | Vial/carton | Compatible meter model is not identified. |
| B | 50 strips | Diagnostic test strips | — | Vial/carton | Compatible meter model is not identified. |
The table reproduces or structures catalogue-level fields. It does not create an approved SKU, instruction or specification where the source record does not provide one.
03 · External reference context
Device and diagnostic background
Blood glucose test strips are in vitro diagnostic consumables used with a specified glucose meter. Their chemical or electrochemical reaction allows the system to estimate glucose in an approved specimen type. They are devices rather than medicines and contain no therapeutic dose. Compatibility, specimen requirements and measurement performance are specific to the complete strip-and-meter system, not to the generic term blood glucose strip.
Intended-use context
Glucose measurements can support diabetes self-management or professional monitoring when the system is authorized for that setting. Results must be interpreted with symptoms and the patient’s clinical plan. A home-use system may not be suitable for all critically ill patients or professional shared-use environments. The catalogue does not establish a measuring range, accuracy claim, patient population or interchangeability with another meter.
Interpretation and safety boundaries
Incorrect strips, degraded reagents, contamination or a sample outside the instructions can produce misleading readings and inappropriate treatment decisions. Interfering substances and physiological conditions depend on the validated system. A reading inconsistent with symptoms needs review according to the care plan. Do not reuse a strip or assume compatibility from its appearance. Blood-contact materials require appropriate infection-prevention and disposal procedures.
Selected external context only. It is not a complete risk profile or Luang Pharma approved labelling. The exact authorised IFU/label and applicable professional guidance control product use.
System, model and handling evidence
The source provides strip counts but does not name a compatible meter or test chemistry. Verify intended use, specimen type, measurement range, interference data, calibration or coding requirements and the exact authorized meter-strip combination.
Keep strips in the manufacturer’s specified container and follow its humidity, temperature, closure and expiry instructions. The allowed period after opening is device-specific. Do not transfer strips to an unlabelled container, and retain lot information for traceability and investigation of unexpected readings.
Final instructions, storage conditions, shelf life and any after-opening/in-use limits require the exact controlled product documentation; none is created from a comparator reference.
Points for professional review
Confirm the complete device system, user population, performance evidence, local registration and instructions for use. Establish training, quality checks and a process for unexpected results.
04 · Layer 04 · Documentation gate
Model, IFU and performance evidence control the device answer.
Before a device/diagnostic record can support procurement, use or compatibility claims, the exact model and intended-use evidence must be identified.
Model/manufacturer identifier.
Instructions for use and exact meter-strip compatibility matrix.
Analytical/performance validation and interference data for the system.
Storage/after-opening specification and lot traceability controls.
Device registration/conformity evidence for the destination.
Editorial source check: archived record dated 2026-09-11.
Qualified product/medical review: Not recorded at B06 checkpoint
Approved Luang Pharma IFU/label: Not provided or established
Registration / availability / supply: not established by this public record.
05 · Layer 03 · Sources & review
External references are attributed, not adopted as Luang Pharma labelling.
| Source | Recorded revision / check | How it is used |
|---|---|---|
| FDA: blood glucose monitoring devicesArchived source classification: government or public health guidance | Archived access check: 2026-09-11 | External reference; not Luang Pharma labelling or evidence of equivalence. |
External sources may describe authorised products, public-health guidance or device classes. They do not establish equivalence, approval, model performance, manufacturing status or supply eligibility for LP-207.
Professional enquiries
Request product-specific evidence for LP-207.
State the exact presentation or configuration, organisation, destination and evidence you need. The public portfolio record is not an offer of supply.